Evidence map›Paper›PMID 24520293›Full record

ArticleOncology letters2014

Effects of AG490 and S3I-201 on regulation of the JAK/STAT3 signaling pathway in relation to angiogenesis in TRAIL-resistant prostate cancer cells

Venhar Gurbuz, Ece Konac, Nuray Varol, Akin Yilmaz, Serhat Gurocak, Sevda Menevse, Sinan Sozen

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Anti-Inflammatory Effect ofMolecules (Basel, Switzerland) · 2024
    Article
  3. Article
  4. Article
  5. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery.Journal of experimental & clinical cancer research : CR · 2024
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Saudi journal of biological sciences · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. The STAT3 inhibitor S3I-201 suppresses fibrogenesis and angiogenesis in liver fibrosis.Laboratory investigation; a journal of technical methods and pathology · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Venhar GurbuzDepartment of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara 06500, Turkey ; Department of Pediatric Infectious Diseases, Faculty of Medicine, Hacettepe University Ankara, Ankara 06100, Turkey.
Ece KonacDepartment of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara 06500, Turkey.
Nuray VarolDepartment of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara 06500, Turkey.
Akin YilmazDepartment of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara 06500, Turkey.
Serhat GurocakDepartment of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara 06500, Turkey ; Department of Urology, Faculty of Medicine, Gazi University, Ankara 06500, Turkey.
Sevda MenevseDepartment of Medical Biology and Genetics, Faculty of Medicine, Gazi University, Ankara 06500, Turkey.
Sinan SozenDepartment of Urology, Faculty of Medicine, Gazi University, Ankara 06500, Turkey.
Gazi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to analyze the molecular mechanisms involved in blocking the signaling pathway and the effects of this on the progression of prostate cancer (CaP) cells

Indexed as

angiogenesisapoptosisJAK and STAT inhibitorsJAK/STAT pathwayprostate cancer

Identifiers

PMID24520293
PMCPMC3919920
OpenAlexW2022052477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.